SCHEMBL8184435

SCHEMBL8184435

C#CCNC(=O)c1c(NC(C)C(C)=O)nc(C#Cc2ccc(OC)c(OC)c2)n1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACB O00763 4/20 0.40
ALDH1A1 P00352 5/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
LMNA P02545 3/20 0.33
GAA P10253 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
MAPT P10636 2/20 0.32
CDK5 Q00535 1/20 0.32
CDK5R1 Q15078 1/20 0.32
TSHR P16473 1/20 0.32
HTT P42858 1/20 0.32
ACHE P22303 1/20 0.32
MAPK1 P28482 2/20 0.31
ALOX15 P16050 1/20 0.31
KDM4E B2RXH2 2/20 0.31
POLB P06746 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
HSD17B10 Q99714 2/20 0.31
GLA P06280 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8188941 0.92 ACACB (0.39) ACACBALDH1A1SMN1; SMN2LMNAGAA
SCHEMBL8184731 0.86 ACACB (0.38) ACACBALDH1A1SMN1; SMN2LMNA
SCHEMBL8183622 0.85 ACACB (0.37) ACACBALDH1A1SMN1; SMN2LMNAGAA
SCHEMBL8180999 0.85 SYK (0.39) ACACBALDH1A1LMNAGAAKDM4E
SCHEMBL8189038 0.85 PGK1 (0.38) ACACBALDH1A1SMN1; SMN2LMNAGAA
SCHEMBL8179729 0.84 ACACB (0.35) ACACBALDH1A1SMN1; SMN2LMNAGAA
SCHEMBL8195154 0.84 CYP3A4 (0.37) ACACBALDH1A1MAPTTSHRKDM4E
SCHEMBL8175218 0.84 ACACB (0.36) ACACBALDH1A1SMN1; SMN2LMNAGAA
SCHEMBL8184729 0.84 CFTR (0.35) ACACBALDH1A1MAPTTSHRHTT
SCHEMBL8179960 0.84 TNF (0.37) ACACBALDH1A1SMN1; SMN2GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008077557-A1 8-ETHINYLXANTHINE DERIVATIVES AS SELECTIVE A2A RECEPTOR ANTAGONISTS SCHWARZ PHARMA AG (DE) 2008-07-03 WO disclosed